아기오스제약(주)
MX ˙ BMV ˙ US00847X1046
SecurityMX:AGIO / Agios Pharmaceuticals, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership10,805 shares
Latest Disclosed Value $ 365,532
ProShare Advisors LLC reports 16.22% decrease in ownership of AGIO / Agios Pharmaceuticals, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 10,805 shares of Agios Pharmaceuticals, Inc. (MX:AGIO) valued at $365,532 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 12,897 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of -16.22% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 10,805 -2,092 -16.22 366 3.99 0.0005
2026-02-06 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 12,897 1,169 9.97 351 -25.32 0.0006
2025-11-06 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 11,728 -2,016 -14.67 471 2.84 0.0010
2025-08-07 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 13,744 -1,077 -7.27 457 5.30 0.0009
2025-05-08 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 14,821 -3,798 -20.40 434 -28.97 0.0010
2025-02-14 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 18,619 4,577 32.60 612 -1.93 0.0014
2024-11-14 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 14,042 3,098 28.31 624 32.27 0.0015
2024-08-13 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 10,944 -2,973 -21.36 472 16.01 0.0013
2024-05-08 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 13,917 1,152 9.02 407 42.96 0.0011
2024-02-14 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 12,765 1,905 17.54 284 5.97 0.0009
2023-11-13 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 10,860 39 0.36 269 -12.42 0.0008
2023-08-10 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 10,821 565 5.51 306 30.21 0.0009
2023-05-26 2023-03-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 10,256 -1,310 -11.33 236 -27.47 0.0007
2023-05-12 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 10,256 -1,310 236 0.0007
2023-02-02 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 11,566 937 8.82 325 8.00 0.0011
2022-11-07 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 10,629 -677 -5.99 300 19.52 0.0012
2022-08-01 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 11,306 -5,770 -33.79 251 -49.50 0.0008
2022-05-10 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 17,076 -3,806 -18.23 497 -27.66 0.0011
2022-02-08 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 20,882 -664 -3.08 687 -30.89 0.0013
2021-11-12 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 21,546 -7,348 -25.43 994 -37.56 0.0028
2021-08-13 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 28,894 18,177 169.61 1,592 187.88 0.0047
2021-05-14 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 10,717 -1,004 -8.57 553 8.86 0.0017
2021-02-09 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 11,721 -408 -3.36 508 19.53 0.0019
2020-11-13 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 12,129 144 1.20 425 -33.70 0.0020
2020-08-03 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 11,985 1,493 14.23 641 72.31 0.0034
2020-05-15 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 10,492 -5,717 -35.27 372 -51.94 0.0027
2020-02-12 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 16,209 -910 -5.32 774 39.46 0.0036
2019-11-12 2019-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 17,119 -1,258 -6.85 555 -39.48 0.0031
2019-08-13 2019-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 18,377 -3,496 -15.98 917 -37.83 0.0055
2019-05-15 2019-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 21,873 666 3.14 1,475 50.82 0.0088
2019-02-14 2018-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 21,207 -4,223 -16.61 978 -50.13 0.0068
2018-11-14 2018-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 25,430 44 0.17 1,961 -8.28 0.0133
2018-08-13 2018-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 25,386 -2,348 -8.47 2,138 -5.73 0.0143
2018-05-14 2018-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 27,734 350 1.28 2,268 44.83 0.0148
2018-02-14 2017-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 27,384 -860 -3.04 1,566 -16.92 0.0109
2017-11-13 2017-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 28,244 2,621 10.23 1,885 43.02 0.0173
2017-08-11 2017-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 25,623 2,380 10.24 1,318 -2.87 0.0131
2017-05-12 2017-03-31 13F/A-2 AGIOS PHARMACEUTICALS COM 00847X104 23,243 -4,983 -17.65 1,357 15.20 0.0142
2017-05-08 2017-03-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 23,243 0 1,357 0.0142
2017-04-25 2017-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 23,243 1,357
2017-02-13 2016-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 28,226 3,241 12.97 1,178 -10.76 0.0130
2016-11-10 2016-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 24,985 -4,125 -14.17 1,320 8.20 0.0184
2016-08-12 2016-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 29,110 525 1.84 1,220 5.08 0.0157
2016-05-06 2016-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 28,585 -2,673 -8.55 1,161 -42.78 0.0160
2016-02-05 2015-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 31,258 1,740 5.89 2,029 -2.64 0.0246
2015-11-06 2015-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 29,518 -284 -0.95 2,084 -37.08 0.0293
2015-08-11 2015-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 29,802 -3,010 -9.17 3,312 7.05 0.0458
2015-05-08 2015-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 32,812 32,812 0.00 3,094 0.0364
2015-01-30 2014-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -23,140 -100.00 0 -100.00
2014-11-06 2014-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 23,140 -4,088 -15.01 1,420 13.78 0.0188
2014-08-08 2014-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 27,228 -3,547 -11.53 1,248 3.57 0.0162
2014-05-07 2014-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 30,775 16,603 117.15 1,205 255.46 0.0151
2014-02-04 2013-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 14,172 14,172 339 0.0051
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.